American Family Children's Hospital
Natalie S. Callander, MD close
Natalie S. Callander, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Natalie S. Callander, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Callander joined the section of Hematology/Bone Marrow Transplant at the University of Wisconsin in October 2004 as an Associate Professor in the Department of Medicine. Dr. Callander has completed residency at Bellevue Hospital in New York and a Hematology/Oncology fellowship at the University of California-San Diego.



UW Health Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital (primary)
Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Hematology
Internal Medicine
Medical Oncology
Fellowship University of California San Diego Medical Center, San Diego, CA
Residency Bellevue Hospital, New York, NY
Internship Bellevue Hospital, New York, NY
Medical School Tufts University School of Medicine, Boston, MA, 1985


Madison Magazine Top Docs 2016

Best Doctors® in America 2015

Madison Magazine Top Docs 2014

UW Health Patient Experience Physician Champion Award 2014

Best Doctors® in America 2014

UW Health Patient Experience Physician Champion Award 2013

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.


Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Programs & Conditions


Her clinical and research interests include: inpatient and outpatient care of hematology and bone marrow transplant patients and multiple myeloma.

PubMed Articles
Hope C Emmerich PB Papadas A Pagenkopf A Matkowskyj KA Van De Hey DR Payne SN Clipson L Callander NS Hematti P Miyamoto S Johnson MG Deming DA Asimakopoulos F . Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. J Immunol. 2017 Jul 28;
[PubMed ID: 28754680]
Hope C Foulcer S Jagodinsky J Chen SX Jensen JL Patel S Leith C Maroulakou I Callander N Miyamoto S Hematti P Apte SS Asimakopoulos F . Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Blood. 2016 Aug 4;128(5):680-5
[PubMed ID: 27259980]
Jared JR Mably MS Makielski R Reed MP Fallon MJ Liu G Mulkerin D Callander NS . Utilization and evaluation of noncore chemotherapy regimens within an academic medical center. J Oncol Pharm Pract. 2016 Jul 6;
[PubMed ID: 27388159]
Lonial S Weiss BM Usmani SZ Singhal S Chari A Bahlis NJ Belch A Krishnan A Vescio RA Mateos MV Mazumder A Orlowski RZ Sutherland HJ Bladé J Scott EC Oriol A Berdeja J Gharibo M Stevens DA LeBlanc R Sebag M Callander N Jakubowiak A White D de la Rubia J Richardson PG Lisby S Feng H Uhlar CM Khan I Ahmadi T Voorhees PM . Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Lancet. 2016 Apr 9;387(10027):1551-60
[PubMed ID: 26778538]
Jurczyszyn A Olszewska-Szopa M Vesole AS Vesole DH Siegel DS Richardson PG Paba-Prada C Callander NS Huras H Skotnicki AB . Multiple Myeloma in Pregnancy--A Review of the Literature and a Case Series. Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):e39-45
[PubMed ID: 26847816]
Hari P Aljitawi OS Arce-Lara C Nath R Callander N Bhat G Allen LF Stockerl-Goldstein K . A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation. Biol Blood Marrow Transplant. 2015 Dec;21(12):2100-5
[PubMed ID: 26327631]
D'Souza A Dispenzieri A Wirk B Zhang MJ Huang J Gertz MA Kyle RA Kumar S Comenzo RL Peter Gale R Lazarus HM Savani BN Cornell RF Weiss BM Vogl DT Freytes CO Scott EC Landau HJ Moreb JS Costa LJ Ramanathan M Callander NS Kamble RT Olsson RF Ganguly S Nishihori T Kindwall-Keller TL Wood WA Mark TM Hari P . Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J Clin Oncol. 2015 Nov 10;33(32):3741-9
[PubMed ID: 26371138]
Scheid C Reece D Beksac M Spencer A Callander N Sonneveld P Kalimi G Cai C Shi M Scott JW Stewart AK . Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation. Eur J Haematol. 2015 Oct;95(4):316-24
[PubMed ID: 25402977]
Stewart AK Jacobus S Fonseca R Weiss M Callander NS Chanan-Khan AA Rajkumar SV . Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma. Blood. 2015 Sep 10;126(11):1294-301
[PubMed ID: 26157076]
Jensen JL Rakhmilevich A Heninger E Broman AT Hope C Phan F Miyamoto S Maroulakou I Callander N Hematti P Chesi M Bergsagel PL Sondel P Asimakopoulos F . Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma. Cancer Immunol Res. 2015 Aug;3(8):881-90
[PubMed ID: 25941352]
Shah N Callander N Ganguly S Gul Z Hamadani M Costa L Sengsayadeth S Abidi M Hari P Mohty M Chen YB Koreth J Landau H Lazarus H Leather H Majhail N Nath R Osman K Perales MA Schriber J Shaughnessy P Vesole D Vij R Wingard J Giralt S Savani BN . Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015 Jul;21(7):1155-66
[PubMed ID: 25769794]
Gupta A Place M Goldstein S Sarkar D Zhou S Potamousis K Kim J Flanagan C Li Y Newton MA Callander NS Hematti P Bresnick EH Ma J Asimakopoulos F Schwartz DC . Single-molecule analysis reveals widespread structural variation in multiple myeloma. Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7689-94
[PubMed ID: 26056298]
Pak C Callander NS Young EW Titz B Kim K Saha S Chng K Asimakopoulos F Beebe DJ Miyamoto S . MicroC(3): an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells. Integr Biol (Camb). 2015 Jun;7(6):643-54
[PubMed ID: 25998180]
Kumar SK LaPlant B Chng WJ Zonder J Callander N Fonseca R Fruth B Roy V Erlichman C Stewart AK . Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma. Blood. 2015 Jan 15;125(3):443-8
[PubMed ID: 25395429]
Sharma M Zhang MJ Zhong X Abidi MH Akpek G Bacher U Callander NS Dispenzieri A Freytes CO Fung HC Gale RP Gasparetto C Gibson J Holmberg LA Kindwall-Keller TL Klumpp TR Krishnan AY Landau HJ Lazarus HM Lonial S Maiolino A Marks DI Mehta P Mikhael Med JR Nishihori T Olsson R Ramanathan M Roy V Savani BN Schouten HC Scott E Tay J To LB Vesole DH Vogl DT Hari P . Older patients with myeloma derive similar benefit from autologous transplantation. Biol Blood Marrow Transplant. 2014 Nov;20(11):1796-803
[PubMed ID: 25046833]
Callander N Markovina S Eickhoff J Hutson P Campbell T Hematti P Go R Hegeman R Longo W Williams E Asimakopoulos F Miyamoto S . Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. Cancer Chemother Pharmacol. 2014 Oct;74(4):875-82
[PubMed ID: 25168296]
Hope C Ollar SJ Heninger E Hebron E Jensen JL Kim J Maroulakou I Miyamoto S Leith C Yang DT Callander N Hematti P Chesi M Bergsagel PL Asimakopoulos F . TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood. 2014 May 22;123(21):3305-15
[PubMed ID: 24723682]
Asimakopoulos F Kim J Denu RA Hope C Jensen JL Ollar SJ Hebron E Flanagan C Callander N Hematti P . Macrophages in multiple myeloma: emerging concepts and therapeutic implications. Leuk Lymphoma. 2013 Oct;54(10):2112-21
[PubMed ID: 23432691]
Hebron E Hope C Kim J Jensen JL Flanagan C Bhatia N Maroulakou I Mitsiades C Miyamoto S Callander N Hematti P Asimakopoulos F . MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages. Br J Haematol. 2013 Mar;160(6):779-84
[PubMed ID: 23252623]
Kim J Denu RA Dollar BA Escalante LE Kuether JP Callander NS Asimakopoulos F Hematti P . Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells. Br J Haematol. 2012 Aug;158(3):336-46
[PubMed ID: 22583117]